Evidence map›Paper›PMID 26260542›Full record

ReviewNature reviews. Nephrology2015

Vascular complications in autosomal dominant polycystic kidney disease.

Ronald D Perrone, Adel M Malek, Terry Watnick

Abstract readReview
In one paragraph

Review in Nature reviews. Nephrology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 69 papers.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed
10.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

69 citing papers in PubMed, 155 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Biology, Physics, and Genetics of Intracranial Aneurysm Formation: A Review.Journal of neurological surgery. Part A, Central European neurosurgery · 2026
    Review
  6. Fusiform dilatation of the ascending aorta and outpouching of the left A2 anterior cerebral artery segment in COL4A1 -related disorder.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026
    Article
  7. Observational
  8. Article
  9. Article
  10. Article
  11. Review
  12. Notch2 Inhibition and Kidney Cyst Growth in Autosomal Dominant Polycystic Kidney Disease.Journal of the American Society of Nephrology : JASN · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Ronald D PerroneDepartment of Medicine, Division of Nephrology, Tufts Medical Center, 800 Washington Street, Boston, MA 02111, USA.
Adel M MalekDepartment of Neurosurgery, Cerebrovascular and Endovascular Division, Tufts Medical Center, 800 Washington Street, Boston, MA 02111, USA.
Terry WatnickDepartment of Medicine, Division of Nephrology, University of Maryland, 720 Rutland Avenue, Baltimore, MD 21205, USA.
Tufts Medical Center · USUniversity of Maryland, Baltimore · US

Funding

Tufts Clinical and Translational Research InstituteUL1TR001064 · NCATS · TUFTS UNIVERSITY BOSTON · PI SELKER, HARRY P. · 2013 to 2017
$26.4M
Research BaseP30DK090868 · NIDDK · UNIVERSITY OF MARYLAND BALTIMORE · PI WATNICK, TERRY J · 2010 to 2019
$11.1M
Polycystic Kidney Disease Clinical Trials NetworkU01DK062411 · NIDDK · TUFTS MEDICAL CENTER · PI PERRONE, RONALD D · 2002 to 2013
$9.3M
Comprehensive Analysis of Polycystin Related Endothelial Cell Signaling PathwaysR01DK095036 · NIDDK · UNIVERSITY OF MARYLAND BALTIMORE · PI WATNICK, TERRY J · 2012 to 2021
$2.3M
PKD1-Fibrillin Interactions and TFG-b Signaling PathwaysR01DK076017 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI WATNICK, TERRY J · 2006 to 2010
$1.5M
NCATS NIH HHS UL1 TR001064NCATS NIH HHS UL1TR001064NIDDK NIH HHS DK076017NIDDK NIH HHS DK095036NIDDK NIH HHS DK62411NIDDK NIH HHS P30 DK090868NIDDK NIH HHS P30DK090868NIDDK NIH HHS R01 DK076017NIDDK NIH HHS R01 DK095036NIDDK NIH HHS U01 DK062411
6 · The paper itself

Abstract

Autosomal dominant polycystic kidney disease (ADPKD) is the most common hereditary kidney disease. Relentless cyst growth substantially enlarges both kidneys and culminates in renal failure. Patients with ADPKD also have vascular abnormalities; intracranial aneurysms (IAs) are found in ∼10% of asymptomatic patients during screening and in up to 25% of those with a family history of IA or subarachnoid haemorrhage. As the genes responsible for ADPKD—PKD1 and PKD2—have complex integrative roles in mechanotransduction and intracellular calcium signalling, the molecular basis of IA formation might involve focal haemodynamic conditions exacerbated by hypertension and altered flow sensing. IA rupture results in substantial mortality, morbidity and poor long-term outcomes. In this Review, we focus mainly on strategies for screening, diagnosis and treatment of IAs in patients with ADPKD. Other vascular aneurysms and anomalies—including aneurysms of the aorta and coronary arteries, cervicocephalic and thoracic aortic dissections, aortic root dilatation and cerebral dolichoectasia—are less common in this population, and the available data are insufficient to recommend screening strategies. Treatment decisions should be made with expert consultation and be based on a risk-benefit analysis that takes into account aneurysm location and morphology as well as patient age and comorbidities.

Indexed as

HumansIntracranial AneurysmPolycystic Kidney, Autosomal DominantVascular Diseases

Identifiers

PMID26260542
PMCPMC4904833
OpenAlexW2233303500

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.